Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Halfon

Showing results (21-30 of 100) with videos related to

Pageof 10
Sort By:
Lancet (London, England)|October 27, 1998
Transfusion transmitted virusV Gerolami, P Halfon, H Chambost, et al.
European Journal of Medicinal Chemistry|May 6, 2008
Prediction of HIV-1 protease inhibitor resistance by Molecular Modeling Protocols (MMPs) using GenMol softwareG Pèpe, J Courcambeck, R Perbost, et al.
AIDS (London, England)|October 16, 2001
Persistence of HIV-1 resistance in lymph node mononuclear cell RNA despite effective HAARTA Lafeuillade, H Khiri, S Chadapaud, et al.
Journal of Clinical Microbiology|March 7, 2001
Molecular evidence of male-to-female sexual transmission of hepatitis C virus after vaginal and anal intercourseP Halfon, H Riflet, C Renou, et al.
AIDS (London, England)|May 1, 1994
Metabolic, hepatic and muscular changes during zidovudine therapy: a drug-induced mitochondrial disease?P Le Bras, R D'Oiron, Y Quertainmont, et al.
Journal of Viral Hepatitis|September 15, 2006
Treatment of hepatitis C virus and human immunodeficiency virus coinfection: from large trials to real lifeP Cacoub, E Rosenthal, P Halfon, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|August 25, 2009
Six-month and lifetime prevalences of psychiatric disorders in inpatients with diabetes mellitusF de Mont-Marin, P Hardy, J Lepine, et al.
HIV Medicine|December 12, 2001
Impact of immune interventions on proviral HIV-1 DNA decay in patients receiving highly active antiretroviral therapyA Lafeuillade, C Poggi, S Chadapaud, et al.
Nephrologie|January 1, 1997
[Clinical significance of detection and quantification of hepatitis C virus RNA in hemodialysis: proposal for a rational diagnostic strategy]P Halfon, S Pol, C Sayada, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 6, 2001
Potential adverse effects of structured therapeutic interruptions on the pool of HIV-infected cellsA Lafeuillade, P Halfon, S Chadapaud, et al.
Pageof 10

Showing results (21-30 of 100) with videos related to

Sort By:
Pageof 10
Lancet (London, England)|October 27, 1998
Transfusion transmitted virusV Gerolami, P Halfon, H Chambost, et al.
European Journal of Medicinal Chemistry|May 6, 2008
Prediction of HIV-1 protease inhibitor resistance by Molecular Modeling Protocols (MMPs) using GenMol softwareG Pèpe, J Courcambeck, R Perbost, et al.
AIDS (London, England)|October 16, 2001
Persistence of HIV-1 resistance in lymph node mononuclear cell RNA despite effective HAARTA Lafeuillade, H Khiri, S Chadapaud, et al.
Journal of Clinical Microbiology|March 7, 2001
Molecular evidence of male-to-female sexual transmission of hepatitis C virus after vaginal and anal intercourseP Halfon, H Riflet, C Renou, et al.
AIDS (London, England)|May 1, 1994
Metabolic, hepatic and muscular changes during zidovudine therapy: a drug-induced mitochondrial disease?P Le Bras, R D'Oiron, Y Quertainmont, et al.
Journal of Viral Hepatitis|September 15, 2006
Treatment of hepatitis C virus and human immunodeficiency virus coinfection: from large trials to real lifeP Cacoub, E Rosenthal, P Halfon, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|August 25, 2009
Six-month and lifetime prevalences of psychiatric disorders in inpatients with diabetes mellitusF de Mont-Marin, P Hardy, J Lepine, et al.
HIV Medicine|December 12, 2001
Impact of immune interventions on proviral HIV-1 DNA decay in patients receiving highly active antiretroviral therapyA Lafeuillade, C Poggi, S Chadapaud, et al.
Nephrologie|January 1, 1997
[Clinical significance of detection and quantification of hepatitis C virus RNA in hemodialysis: proposal for a rational diagnostic strategy]P Halfon, S Pol, C Sayada, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 6, 2001
Potential adverse effects of structured therapeutic interruptions on the pool of HIV-infected cellsA Lafeuillade, P Halfon, S Chadapaud, et al.
Pageof 10